Ionis Pharmaceuticals | IONS - Ebitda





Ebitda Veränderung Datum
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Arrowhead Research USD -147.68M 40.33M 2026-06
Astellas Pharma JPY 235.24B 136.32B 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Celltrion KRW 19.64B 1.85B 2026-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Exelixis USD 255.4M 2.89M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Omeros USD -47.96M 7.39M 2023-09
OPKO Health USD -27.82M 103.34M 2026-03
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pfizer USD 6.01B 18M 2026-06
Pharma Mar EUR 700K 2.01M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Qiagen NV USD 207.66M 59.56M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Sartorius EUR 280.5M 13.2M 2026-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03